Below is a chart summarizing top recently funded (2017) projects at Duke University in terms of NIH Level Research funding:
| Project | Group | Funding |
| CENTER FOR HIV/AIDS VACCINE IMMUNOLOGY AND IMMUNOGEN DISCOVERY | NIAID | $33,697,405 |
| INDUCTION OF PROTECTIVE B-CELL RESPONSES TO HIV-1 | NIAID | $22,790,537 |
| ECHO COORDINATING CENTER | OD | $18,172,311 |
| PROJECT-005 | OD | $12,872,250 |
| DUKE CTSA (COMPOSITE) | NCATS | $8,821,156 |
| ANTIBACTERIAL RESISTANCE LEADERSHIP GROUP (ARLG) | NIAID | $8,000,000 |
| HEART FAILURE CLINICAL RESEARCH NETWORK COORDINATING CENTER | NHLBI | $6,824,782 |
| CENTER FOR INNOVATIVE TRIALS IN CHILDREN AND ADULTS (TRIDENT) | NCATS | $6,156,391 |
| CANCER CENTER SUPPORT GRANT | NCI | $5,679,062 |
| DUKE CLINICAL GOOD MANUFACTURING PRACTICES FACILITY FOR HIV/AIDS VACCINE PRODUCTION | OD | $4,900,000 |
| CENTERS FOR MEDICAL COUNTERMEASURES AGAINST RADIATION | NIAID | $4,698,865 |
| PROJECT-003 | OD | $4,544,270 |
| INCREASING THE QUALITY AND EFFICIENCY OF CLINICAL TRIALS (R18) | FDA | $3,785,000 |
| OPERATIONS AND MANAGEMENT SUPPORT COMPONENT | NIAID | $3,560,733 |
| METABOLIC NETWORK ANALYSIS OF BIOCHEMICAL TRAJECTORIES IN ALZHEIMER'S DISEASE | NIA | $3,509,523 |
| BRIDGING ANTIBODY FC-MEDIATED ANTIVIRAL FUNCTIONS ACROSS HUMANS AND NON-HUMAN PRIMATES | NIAID | $3,241,864 |
| Total |
$151,254,149 \ |
Event Details:
Last year, the BioResearch Product Faire™ Event at Duke University attracted 265 attendees. Of these attendees, 53 were purchasing agents, professors and post docs, and 39 were lab managers. Attendees came from 22 different research buildings and 37 on-campus departments. Duke is top tier research University with lots of funding each year. Exhibitors reported excellent returns on participating in this event.
Next Event at Duke 5/24/2018
Looking to participate at other on campus vendor show across the nation? Click below to receive more information: